Assessment of drug efficacy and safety is challenging without a predictive model. We provide hiPSC-based solutions for neural and cardiovascular drug screening, including Efficacy Services, Safety Services, Drug Discovery Assays, and Cell Models.

We combine our cardiovascular and neural cell knowledge with commercial expertise in large-scale manufacturing and process development to enable drug developers to bring predictive human disease biology earlier into the drug discovery process.